The present study was performed to identify sequence(s) in the third intracellular loop (i3) of the muscarinic acetylcholine receptor M4 subtype (M4 receptor) involved in its internalization and recycling. In transiently transfected human embryonic kidney 293-tsA201 cells, 40 to 50% of cell-surface M4 receptors are internalized in an agonist-dependent manner, and approximately 65% of internalized receptors are recycled back to the cell surface after removal of the agonist. We examined the internalization and recycling of M4 receptor mutants with partial deletion in i3 and found that various mutants (M4del-K 235 -K 240 , M4del-T 241 -K 271 , and M4del-W 339 -N 372 ) showed internalization and cell-surface recycling in a similar manner to the M4 receptor. We also found that the mutant M4del-L 272 -R 338 was internalized to only half the extent of the M4 receptor and was recycled after agonist removal, and the mutant M4del-V 373 -A 393 was also internalized to half the extent of the wild type but was not recycled back to the cell surface after agonist removal. When the sequence corresponding to Val 373 -Ala 393 was grafted onto the i3 portion of a recycling-negative mutant of muscarinic M2 receptor with deletion of almost the whole of the i3 sequence, approximately 40% of the chimeric receptor on the cell surface was internalized, and more than 65% of the internalized receptors were recycled back to the cell surface. 
recycled after agonist removal, and the mutant M4del-V 373 -A 393 was also internalized to half the extent of the wild type but was not recycled back to the cell surface after agonist removal. When the sequence corresponding to Val 373 -Ala 393 was grafted onto the i3 portion of a recycling-negative mutant of muscarinic M2 receptor with deletion of almost the whole of the i3 sequence, approximately 40% of the chimeric receptor on the cell surface was internalized, and more than 65% of the internalized receptors were recycled back to the cell surface. These results indicate that the regions including Leu 272 -Arg 338 and Val 373 -Ala 393 are involved in internalization of the M4 receptor, and the region including Val 373 -Ala 393 is indispensable for its recycling, whereas the other regions of i3 are dispensable for internalization and recycling.
Prolonged exposure to agonists of G protein-coupled receptors (GPCRs) usually results in attenuation of cellular responses (desensitization). One molecular mechanism of desensitization involves the phosphorylation of the receptors by G protein-coupled receptor kinases (GRKs) and increased binding of the inhibitory protein ␤-arrestin to the phosphorylated receptors, thereby inhibiting their coupling with G proteins (Claing et al., 2002) . Another mechanism is the internalization of receptors by which they become inaccessible to hydrophilic, membrane-impermeable ligands, including agonists. The internalization of receptors occurs via clathrin-coated vesicles, caveolae, or noncoated vesicles (Feron et al., 1997; Vögler et al., 1999) . After internalization, some GPCRs can be recycled back to the plasma membrane as functional receptors to allow resensitization of desensitized receptors. Receptor internalization may also be an intermediate step preceding degradation in the lysosomes (down-regulation).
The muscarinic acetylcholine receptor (mAChR) family consists of five subtypes and can be subdivided into two functional groups: M1, M3, and M5 subtypes, which couple to the G q family of G proteins; and the M2 and M4 subtypes, which couple to the G i family of G proteins (Caulfield and Birdsall, 1998) . It has been reported that M4 receptors undergo internalization via clathrin-coated pits after activation by agonist and a large proportion of internalized M4 receptors can be recycled back to the plasma membrane after agonist removal (Bogatkewitsch et al., 1996) , whereas M2 receptors, which are functionally and structurally homologous to M4 receptors, undergo internalization via a nonclathrin pathway and a small proportion of internalized M2 receptors is recycled (Vögler et al., 1998; Delaney et al., 2002) . The molecular mechanism of mAChR desensitization remains unclear, although several reports have indicated the involvement of various proteins, such as GRK, arrestin, clathrin, dynamin, and Rab GTPases in the internalization and recycling of muscarinic receptors Lee et al., 1998; Vögler et al., 1999; Schlador et al., 2000; Delaney et al., 2002) . Little is known about which domain(s) of receptors participate in endocytic trafficking, especially in endocytic recycling, although the third intracellular loop (i3) was suggested to be involved in agonist-dependent internalization of M1 and M2 receptors (Maeda et al., 1990; Goldman et al., 1996; Tsuga et al., 1998) . i3 is thought to be indispensable for agonist-induced internalization of M2 receptors, because with deletion of i3, internalization of the M2 receptor mutant was abolished in CHO cells (Tsuga et al., 1998) . In the case of M2 receptors, i3 presents sites for phosphorylation by GRK2 in an agonist-dependent manner, and its phosphorylation facilitates M2 receptor internalization . On the other hand, little is known about the role of M4 receptor i3 in internalization and recycling, with the exception of the report by Van Koppen et al. (1994) in which deletion of a large portion of i3 had little effect on its internalization.
In the present study, we screened for motif(s) in i3 of M4 receptors involved in agonist-dependent internalization and recycling and found a sequence that is indispensable for its recycling. This motif is completely distinct from sequences reported to be indispensable for recycling of other GPCRs (Gage et al., 2001; Kishi et al., 2001; Tanowitz and von Zastrow, 2003; Vargas and von Zastrow, 2004; Paasche et al., 2005) . The location of this motif, i3 of the M4 receptor, is also distinct from those of previously identified motifs, all of which reside in the carboxyl-terminal tails of the receptors. To the best of our knowledge, results in the present study provide the first evidence for the presence of a sequence in mAChR, which is functionally similar to "the recycling motif" but structurally distinct from the one reported for other GPCRs. The M4 receptor is known to be a target for antiparkinsonian drugs. Detailed knowledge on desensitization/resensitization of the M4 receptor may be useful for drug treatment of the disease, understanding of tolerance to drugs, and development of new drugs.
Materials and Methods

Materials. N-[
3 H]Methylscopolamine ([   3   H ]NMS, 80 Ci/mmol) was purchased from GE Healthcare (Chalfont St. Giles, UK), the mammalian expression vector pcDNA3 was from Invitrogen (Carlsbad, CA), Dulbecco's phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , pH 7.5) was from Sigma-Aldrich (St. Louis, MO), and restriction enzymes were from Toyobo Corp. (Osaka, Japan). A cDNA of human muscarinic acetylcholine receptor M4 subtype (M4 receptor) was provided by Dr. T. I. Bonner (National Institutes of Health, Bethesda, MD), a cDNA of human muscarinic acetylcholine receptor M2 subtype (M2 receptor) was provided by Dr. W. Sadée (University of California, San Francisco, CA).
Construction of Mammalian Expression Vectors.
The open reading frames (ORFs) of human muscarinic acetylcholine receptor M4 and M2 subtypes were subcloned into pcDNA3 (Invitrogen) using BamHI/NotI and EcoRI/NotI sites, respectively. The M4 receptor consists of coding nucleotides 1 to 1440. An M4 receptor mutant ( The two sets of primers were used in two separate PCRs to amplify overlapping DNA fragments. The overlapping fragments were mixed and used as the template for the third round of PCR, in which a full-length DNA encoding the M4 receptor mutant, M4del-K 235 -A 393 , was generated using two primers (P2 and P3). The resulting DNA fragment was excised with BamHI and NotI and ligated into the BamHI/NotI sites of pcDNA3. Expression constructs of a series of M4 receptor mutants with a partial deletion in i3 were generated by the same method as described for construction of the M4del-K 235 -A 393 expression vector, although overlapping sequence lengths of the first and second PCR products varied from 21 to 37 bases. To construct a chimeric mutant of the M2 receptor with the i3 of the M4 receptor, designated M2(M4i3)M2, the ORF of the M2 receptor cDNA was subcloned into the HindIII/EcoRI site of pUC18 to produce a vector designated pUC-m2. To replace the majority of the i3 of the M2 receptor (Arg 211 -Thr 388 , coding nucleotides 631-1164) with the corresponding region of the M4 receptor (Leu 220 -Thr 401 , coding nucleotides 658 -203), silent mutations were introduced to generate an NruI site and an MluI site at 5Ј-and 3Ј-terminal region of M2-i3 in pUC-m2, respectively. The cDNA encoding M4 receptor (Leu 220 -Thr 401 ) was amplified by PCR using primers with NruI and MluI sites at their termini and inserted into pUC-m2 to produce a cDNA encoding M2(M4i3)M2, and the resulting construct was designated pUC18-M2(M4i3)M2. The cDNA encoding full-length M2(M4i3)M2 was excised and subcloned into pcDNA3. A chimeric mutant of the M2 receptor with the carboxyl-terminal half of M4-i3, in which a region of M2-i3 (Ser 283 -Thr 388 ) was replaced by the corresponding region of M4-i3 (Ser 297 -Thr 401 ), was generated as follows. The cDNA encoding the amino-terminal half of M2-i3 (Arg 211 -Ser 283 ) was amplified by PCR using two primers with NruI and SacI sites at their 5Ј termini, respectively, and ligated into the NruI/SacI sites of pUC18-M2(M4i3)M2. The resulting plasmid was excised and ligated into the pcDNA3 vector and designated pcDNA3-M2(M2i3(208 -283)-M4i3(298 -401))M2. An M2 receptor mutant with deletion of most of i3 (deletion of residues from Ser 234 to Arg 381 ) (M2del-S 234 -R 381 ϭ M2del-i3) was generated by the same method as described for construction of M4del-K 235 -A 393 . The deleted region of M2del-i3 was identical to that of the i3-deleted M2 mutant described previously (Tsuga et al., 1998) Nucleotide sequences of all constructs were confirmed by DNA sequencing using a 3100-Avant Genetic Analyzer (Applied Biosystems, Foster City, CA). All plasmids were amplified and purified by using QIAfilter Plasmid Midi Kits (QIAGEN GmbH, Hilden, Germany).
Cell Culture. Human embryonic kidney (HEK) 293-tsA201 (Margolskee et al., 1993) cells were cultured in Dulbecco's modified Eagle's medium/F-12 (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen), 100 g/ml penicillin, and 100 U/ml streptomycin (Invitrogen) at 37°C in a 5% CO 2 environment.
Transfection of Mammalian Expression Vectors and Radioligand Binding Assay. HEK293-tsA201 cells (approximately 50 -60% confluence) were transiently transfected with muscarinic receptor expression vectors on 10-cm-diameter dishes using Lipofectamine 2000 (Invitrogen) essentially according to the manufacturer's instructions. The amounts of DNA used ranged from 0.25 to 6 g/dish. Twenty-four hours after transfection, the cells were plated (2 ϫ 10 5 cells/well) onto 24-well culture dishes coated with poly-D-lysine (BD Biosciences, Franklin Lakes, NJ). Forty-eight hours after transfection, the cells were stimulated with carbamylcholine (CCh; final, 100 M; Sigma-Aldrich) for various periods up to 180 min and then used for examination of receptors on the cell surface. For the recycling experiments, the cells were incubated with 100 M CCh for 1 h and then washed with PBS supplemented with 0.8 mM CaCl 2 and 0.33 mM MgCl 2 [PBS(ϩ)] followed by incubation in CCh-free medium for various periods. After incubation, the cells were washed with PBS(ϩ) and incubated on ice for 2 h with 1 nM [ 3 H]NMS in HEPES-buffered Dulbecco's modified Eagle's medium/F-12 (Invitrogen) in the presence or absence of 1 M atropine sulfate (Wako Pure Chemical Industries, Osaka, Japan) to measure nonspecific and total binding, respectively. After incubation with [ 3 H]NMS, cells were washed with icecold PBS(ϩ) three times and lysed in 0.25 ml of 1% (v/v) Triton X-100 (Nacalai Tesque, Kyoto, Japan) and mixed with 3.5 ml of liquid-scintillation cocktail [70% (v/v) toluene (Nacalai Tesque), 30% (v/v) Triton X-100, 0.4% (w/v) 2,5-diphenyloxazole (Sigma-Aldrich), and 0.01% (w/v) 1,4-bis-2-(methyl-5-phenyloxazolyl)benzene (Wako Pure Chemical Industries)] (Tsuga et al., 1998) , and the radioactivity of the suspension was measured using a liquid scintillation counter. Triplicate or quadruplicate measurements were performed for each point. Internalization and recycling of receptors were estimated as the decrease and increase, respectively, of binding sites for the membrane-impermeable muscarinic ligand, [
3 H]NMS (Galper et al., 1982) .
Results
Muscarinic M4 or M2 receptors were transiently transfected into HEK293-tsA201 cells and subjected to agonistdependent internalization by exposure to 100 M carbamylcholine. Forty to 50% of cell-surface M4 receptors underwent internalization with t 1/2 of 16 Ϯ 2.0 min (mean Ϯ S.E.) and 65% of internalized M4 receptors recycled back to the cell surface after agonist removal ( Fig. 2A) . Under essentially the same conditions, approximately 90% of cell-surface M2 receptors underwent internalization, and approximately 33% of internalized M2 receptors recycled back to the cell surface after agonist removal (Fig. 2B) .
The role of i3 in internalization and recycling was examined for both M2 and M4 receptors using mutants with deletion of i3 of M4 and M2 receptors. We have prepared an M4 receptor mutant with deletion of most of i3 (M4del-K  235 -A   393 or M4del-i3), in which only 18 and 8 amino acid residues at the amino-and carboxyl-terminal junctions of i3 are retained, respectively (Fig. 1) . Affinities of CCh for wild-type M4 receptor (M4 WT) and M4del-i3 were estimated from the displacement by CCh of [ 3 H]NMS binding and were shown to be similar to each other (Fig. 3) . The IC 50 values of CCh for M4 WT and M4del-i3 were estimated to be 29 Ϯ 4.1 (mean Ϯ S.E.) and 21 Ϯ 0.72 M (mean Ϯ S.E.), respectively, and there was no significant difference in these two values. M4del-i3 showed significant internalization with a t 1/2 of 21.8 Ϯ 1.8 min (mean Ϯ S.E.), although the proportion of internalized receptors (20 -30%) decreased to approximately half of that of the M4 WT (Fig. 2, A and C) . In contrast, an M2 receptor mutant with deletion of most of i3 (M2del-S 234 -R 381 or M2del-i3), in which 26 and 7 amino acid residues at the amino-and carboxyl-terminal junctions of i3 are retained, respectively (Fig. 1) , underwent internalization with a longer t 1/2 of 47.2 Ϯ 4.0 min (mean Ϯ S.E.) (Fig. 2D) . This value for t 1/2 was approximately 5-fold higher than that for internalization of the wild-type M2 receptor (M2 WT), which was 8.5 Ϯ 1.2 min (Fig. 2B) . Little recycling of internalized receptors after agonist removal was observed for either M2del-i3 or M4del-i3, in contrast to M2 and M4 receptors (Fig. 2, C and  D) . Figure 4 shows effects of carbamylcholine concentrations on the proportion of internalized wild-type M4 receptors (Fig.  4A ) and M4 receptor mutants with deletion of most of i3 (Fig.  4B ). There was no significant difference in the potency of carbamylcholine to induce internalization between M4 WT [half-maximal value of 5.36 Ϯ 0.73 M (mean Ϯ S.E.)] and M4del-i3 [half-maximal value of 4.32 Ϯ 0.97 M (mean Ϯ S.E.)].
To determine whether the region in i3 is involved in agonist-dependent internalization and recycling of M4 receptors, we constructed various M4 receptor mutants with partial deletion in i3 (Fig. 1) and examined their internalization and recycling. All of these M4 mutants (Fig. 5A (Fig. 5, E and F) . The level of internalization was 25 to 60% for the former mutants and 20 to 25% for the latter. It is possible that a certain proportion of internalized receptors needs to be reached before it enters a recycling pathway. This possibility, however, is not likely to be the case because the significant recycling of M4del-L 272 -R 338 receptors with 23% internalization was observed, whereas no significant recycling of M4del-i3 receptors with 30% internalization was observed (Fig. 2C) . In the former case, we took advantage that the level of internalization is decreased by the increase in expression level (data not shown). These results indicate that the recycling capability depends on particular sequence in i3, but not in the level of internalization, and that a sequence from Val 373 to Ala 393 is required for the recycling of M4 receptors.
Next, we examined whether the partial sequences of M4-i3, Val 373 -Ala 393 or Ser 298 -Ala 393 , are sufficient to enable recycling of the recycling-negative receptor. The whole or partial i3 sequences of M4 receptors were incorporated into M2del-i3, which shows a low level of internalization at a slow rate (Fig. 2D) . All chimeric mutants, M2(M4i3)M2, M2(M4(V 373 - 
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A 393 ))M2, and M2(M4(S 298 -A 393 ))M2, were found to internalize to a similar extent to the M4 receptors, and the internalized receptors were recycled after removal of agonist (Fig. 6 , A-C). The proportions of recycled receptors were 100, 65.8 Ϯ 5, and 70.7 Ϯ 3.5% for M2 (M4i3) 
Discussion
Muscarinic acetylcholine receptors as well as ␣ 2A-2C adrenergic, dopaminergic D 2-4 , and serotonergic 5HT 1A receptors possess a long i3 with more than 150 residues, but the functional role of these long i3 in receptors has not been fully elucidated. Only membrane-proximal regions in the i3 of M1 and M2 muscarinic receptors are known to be required for the interaction with G proteins (Maeda et al., 1990; Kameyama et al., 1994; Wess et al., 1997) , and most of the central part of i3 of M1, M2, and M3 muscarinic receptors can be deleted without losing ligand-binding ability or G proteinactivating activity (Shapiro and Nathanson, 1989; Moro et al., 1993; Kameyama et al., 1994) . On the other hand, the jpet.aspetjournals.org central part of i3 appears to be responsible for regulation of receptors. The i3 of M2 has been shown to be the site for phosphorylation (Nakata et al., 1994) and for interaction with G␤␥ (Wu et al., 1998) ; i3 of M3 has been shown to be the site for interaction with proteins, such as ␤-arrestin, G␤␥, casein kinase 1␣, and SET (Wu et al., 1997 (Wu et al., , 2000 Budd et al., 2000; Simon et al., 2006) ; i3 of M1 has been shown to be the site for interaction with regulators of G protein signaling (Bernstein et al., 2004) ; and i3 of M4 has been shown to be the site for interaction with elongation factor (McClatchy et al., 2002) .
It has been suggested that the i3 is involved in agonistdependent internalization of M1, M2, M3, and M4 muscarinic receptors (Lameh et al., 1992; Lee and Fraser, 1993; Moro et al., 1993; Van Koppen et al., 1994; Goldman et al., 1996; Tsuga et al., 1998) . Consistent with previous work (Tsuga et al., 1998) , i3 deletion of M2 receptors was shown to impair its rapid internalization (Fig. 2D) . Van Koppen et al. (1994) reported that deletion of a large portion of i3 (residues from Glu 264 to Arg 394 ) decreased the rate and proportion of M4 receptor internalization. Our findings are essentially consistent with their results (Fig. 2C) , although the proportions of internalized M4 or i3-deleted M4 receptors were different between the two studies. This may be due to differences in the cells used. The results of both the present study and those reported by Van Koppen et al. (1994) indicate that M4 receptors can internalize without most of i3 in contrast to M2 receptors, which are hardly internalized without most of i3.
Without most of i3, M4 receptors are internalized with a similar potency of CCh (Fig. 4) , but the proportion of internalization was reduced to approximately half of that observed for M4 receptors with i3 (Fig. 2) , and no recycling was observed (Fig. 2) . M4del-i3 as well as M4 WT has the ability to interact with G proteins, G o (data not shown), and then the apparent decrease in internalization of M4del-i3 is not due to the loss in G protein-activating ability followed by the decreased availability of G␤␥ subunit and the reduction of GRK2 activity. Thus, using a series of M4 receptor mutants with partial deletions of i3, we searched for portions of the i3 that are involved in its agonist-dependent internalization and recycling. We found that the proportion of internalized receptors did not change appreciably for mutants with deletion in Lys . These results are consistent with the idea that several types of mechanism are active in M4 receptor internalization: an i3-independent mechanism and an i3-dependent mechanism. Based on this assumption, the i3-independent internalization does not require most part of i3, and the i3-dependent internalization requires the two regions in i3 [ is not required for recycling of internalized receptors. Based on the assumption of two internalization pathways, the latter mutant with a deletion in Leu 272 -Arg 338 is thought to be internalized through the i3-independent pathway and to be recycled back to the cell surface through the i3-dependent pathway because the mutant with deletion of most of i3 does not undergo recycling. It is likely that the sequence Val 373 -Ala 393 is responsible for recycling of receptors internalized through either the i3-dependent or -independent pathway. This was supported by the observation that insertion of the M4 sequence (Val 373 -Ala 393 ) into an i3-deleted M2 receptor mutant enabled the resulting chimeric receptor to be internalized and recycled back to the cell surface in an agonist-dependent manner. The simplest interpretation of these results is that the sequence Val 373 -Ala 393 is necessary and sufficient for internalization and recycling of the M2-M4 chimeric receptor, although the possibility remains that other regions, such as the first and second intracellular loops and carboxyl-terminal tail, or amino-or carboxyl-terminal regions of i3, are also involved.
M4 receptor mutants with deletions in various regions of i3 were expressed at approximately the same level as the wildtype M4, bound to muscarinic agonists or antagonists, and were internalized in an agonist-dependent manner. These results are not consistent with the suggestion that the central part of i3 forms a rigid structure that is responsible for internalization but are consistent with the idea that it adopts a flexible structure with short segments that are responsible for internalization and recycling. Recently, the i3 of M2 receptor has been shown to have a flexible structure with no secondary structure (Ichiyama et al., 2006) . It is reasonable to assume that the i3 of M4 also has a flexible structure.
It is interesting that the identified recycling sequence Val 373 -Ala 393 within the i3 of the M4 receptor has no homology to previously identified signal sequences present at the extreme carboxyl terminus or in a distal portion of the carboxyl-terminal tail of several GPCRs (Gage et al., 2001; Kishi et al., 2001; Tanowitz and von Zastrow, 2003; Vargas and von Zastrow, 2004; Paasche et al., 2005) . The regulatory mechanism of recycling of GPCRs with a large i3 may be different from that of GPCRs, the recycling of which is regulated by the carboxyl-terminal tail of the receptor.
It will be reasonable to assume that the sequence, Val 373 -Ala 393 , interacts with some protein(s), thereby modulating receptor recycling. One of possible candidates for interaction with the sequence is ␤-arrestin 1 (Vögler et al., 1999) . We examined the effects of wild-type and dominant-negative (V53D) ␤-arrestin 1 on agonist-dependent internalization and recycling. Overexpression of either V53D ␤-arrestin 1 or wild-type ␤-arrestin 1 did not appreciably affect recycling or internalization of wild-type M4 receptor, although more than severalfold of expression of ␤-arrestin 1 proteins were confirmed by Western blot analysis (data not shown). Dominantnegative (V54D) ␤-arrestin 2 (Ferguson et al., 1996) also did not affect internalization of wild-type M4 receptor. Another candidate for interaction with the sequence might be elongation factor 1A, which was reported to interact with i3 of M4 receptors (McClatchy et al., 2002) and inhibit recycling of M4 receptors (McClatchy et al., 2006) . It remains to be elucidated whether elongation factor 1A may interact with the region, Val 373 -Ala 393 , and compete with the putative protein(s) that interact with the region and facilitate the recycling.
In the present study, we identified a novel recycling signal sequence present in the i3 of the M4 receptor. To our knowledge, this is the first report of a recycling sequence present in the i3, although it has already been reported that a tyrosine residue in the i3 is involved in the recycling of mouse neurotensin type 2 receptor, which has a short i3 of 56 amino acid residues (Martin et al., 2002) . Our study provides a clue to the molecular mechanism of mAChR desensitization/resensitization. It also strengthens the emerging concept that GPCR recycling is a regulated process using a short segment in intracellular sites of receptors. Further studies are required to identify a cytoplasmic protein that interacts with this signal sequence and facilitates M4 receptor recycling.
